Charterhouse begins groundwork for $700 million-plus Doc Generici sale -sources
By Pamela Barbaglia LONDON (Reuters) – European buyout firm Charterhouse [CHCAP.UL] is preparing for the sale of its Italian generic…
Pharmaceuticals, Biotechnology and Life Sciences
By Pamela Barbaglia LONDON (Reuters) – European buyout firm Charterhouse [CHCAP.UL] is preparing for the sale of its Italian generic…
Hikma Pharmaceuticals has prepared a combined Prospectus that contains the formal notice of meeting for the general meeting, to be…
Five charged in U.S. with stealing secrects from GlaxoSmithKline
Glenmark Pharmaceuticals entering $130M market with Actavis’ Potassium Cholire capsules and generics of Warner Chilcott’s Loestrin tablets
Indian pharmaceutical company Natco Pharma Limited has signed a nonexclusive, royalty free licensing agreement with the Medicines Patent Pool and…
Former drug executive Martin Shkreli plans to hire new legal counsel to represent him against U.S. charges that he defrauded investors at his former hedge fund and a pharmaceutical company he headed, Shkreli’s current lawyers said.
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has decided to cancel the admission of its ordinary shares to trading…
Eurostars grant awarded to international consortium including Abzena company, Antitope, for development of novel treatment for clotting disorders
One person has been left brain dead and five others have been hospitalised after taking part in a clinical trial in France of an experimental drug made by Portuguese drug company Bial, French Health Minister Marisol Touraine said on Friday.
Premaitha Health PLC welcomes the UK National Screening Committee’s (NSC) recommendation to routinely offer NIPT testing on the NHS to…